189 related articles for article (PubMed ID: 33629759)
1. Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype.
Shaltiel T; Zheng S; Siderides C; Gleeson EM; Carr J; Pletcher ER; Cohen NA; Golas BJ; Magge DR; Labow DM; Branch AD; Sarpel U
Cancer; 2021 May; 127(9):1395-1406. PubMed ID: 33629759
[TBL] [Abstract][Full Text] [Related]
2. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
[TBL] [Abstract][Full Text] [Related]
3. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
[TBL] [Abstract][Full Text] [Related]
4. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.
Li Q; Li H; Qin Y; Wang PP; Hao X
J Gastroenterol Hepatol; 2007 Nov; 22(11):1936-41. PubMed ID: 17914973
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of prognosis of small hepatocellular carcinoma patients with hepatitis B virus infection versus hepatitis C virus infection].
Li HK; Qin Y; Li XM; Li Q
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):426-8. PubMed ID: 19567020
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America.
Hwang SJ; Tong MJ; Lai PP; Ko ES; Co RL; Chien D; Kuo G
J Gastroenterol Hepatol; 1996 Oct; 11(10):949-54. PubMed ID: 8912133
[TBL] [Abstract][Full Text] [Related]
7. Influence of hepatitis viruses on clinicopathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma.
Tanase AM; Dumitrascu T; Dima S; Grigorie R; Marchio A; Pineau P; Popescu I
Hepatobiliary Pancreat Dis Int; 2014 Apr; 13(2):162-72. PubMed ID: 24686543
[TBL] [Abstract][Full Text] [Related]
8. Recent trends of Japanese hepatocellular carcinoma due to HCV in aging society.
Hiraoka A; Hidaka S; Shimizu Y; Utsunomiya H; Imai Y; Tatsukawa H; Tazuya N; Yamago H; Yorimitsu N; Tanihira T; Hasebe A; Miyamoto Y; Ninomiya T; Kawasaki H; Hirooka M; Abe M; Hiasa Y; Matsuura B; Onji M; Michitaka K
Hepatogastroenterology; 2012 Sep; 59(118):1893-5. PubMed ID: 22193439
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
Aljumah AA; Kuriry H; Faisal N; Alghamdi H
Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.
Yosry A; Abdel-Rahman M; Esmat G; El-Serafy M; Omar A; Doss W; Zayed N; Said M; Ismail T; Hosny A; Marawan E; El-Malt O; Kamel RR; Hatata Y; El-Taweel A; Ghali A; Sabri H; Kamel S; El-Gabaly H
Exp Clin Transplant; 2009 Sep; 7(3):157-63. PubMed ID: 19715525
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis.
Vidal RIO; Vidal EIO; Pereira BB; Assane CC; Ribeiro A; do Nascimento EM; Romeiro FG; Ribeiro Filho J
Biomed Res Int; 2020; 2020():1487593. PubMed ID: 33134370
[TBL] [Abstract][Full Text] [Related]
13. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
14. Macrotrabecular Hepatocellular Carcinoma: An Aggressive Subtype of Hepatocellular Carcinoma.
Jeon Y; Benedict M; Taddei T; Jain D; Zhang X
Am J Surg Pathol; 2019 Jul; 43(7):943-948. PubMed ID: 31135484
[TBL] [Abstract][Full Text] [Related]
15. Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
Lewin M; Gelu-Simeon M; Ostos M; Boufassa F; Sobesky R; Teicher E; Meyer L; Fontaine H; Salmon-Céron D; Samuel D; Seror O; Trinchet JC; Duclos-Vallée JC
Radiology; 2015 Nov; 277(2):443-53. PubMed ID: 25961631
[TBL] [Abstract][Full Text] [Related]
16. The adverse characteristics of hepatocellular carcinoma in the non-cirrhotic liver disproportionately disadvantage Black patients.
Shaltiel T; Sarpel U; Branch AD
Cancer Med; 2024 Feb; 13(3):e6654. PubMed ID: 38230878
[TBL] [Abstract][Full Text] [Related]
17. HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
Lee MH; Hsiao TI; Subramaniam SR; Le AK; Vu VD; Trinh HN; Zhang J; Jin M; Wong VW; Wong GL; Nguyen MH
Am J Gastroenterol; 2017 Jul; 112(7):1111-1119. PubMed ID: 28440303
[TBL] [Abstract][Full Text] [Related]
18. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.
Giannini E; Risso D; Botta F; Romagnoli P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Testa R
J Intern Med; 2004 Mar; 255(3):399-408. PubMed ID: 14871465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]